High Grade B-Cell Lymphoma — Trials

High Grade B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

142 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 84
Recruiting: 45
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 46.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04914741	A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)(COALITION)	unknown	Phase 1 / Phase 2	80	Peter MacCallum Cancer Centre, AustraliaOTHER	1	Aug 12, 2024	clinicaltrials
NCT05974085	XPO-1 in Combination With RCHOP for DH/TH Lymphoma	unknown	Phase 2	10	Zhejiang Cancer HospitalOTHER	1	Aug 3, 2023